1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monoclonal Antibodies 1.2.3 Interferon 1.2.4 Erythropoietin 1.2.5 Insulin 1.2.6 Vaccines 1.2.7 Other 1.3 Market by Application 1.3.1 Global Biosimilar of Remicade Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Biosimilar of Remicade Market Perspective (2016-2027) 2.2 Biosimilar of Remicade Growth Trends by Regions 2.2.1 Biosimilar of Remicade Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Biosimilar of Remicade Historic Market Share by Regions (2016-2021) 2.2.3 Biosimilar of Remicade Forecasted Market Size by Regions (2022-2027) 2.3 Biosimilar of Remicade Industry Dynamic 2.3.1 Biosimilar of Remicade Market Trends 2.3.2 Biosimilar of Remicade Market Drivers 2.3.3 Biosimilar of Remicade Market Challenges 2.3.4 Biosimilar of Remicade Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biosimilar of Remicade Players by Revenue 3.1.1 Global Top Biosimilar of Remicade Players by Revenue (2016-2021) 3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2016-2021) 3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Biosimilar of Remicade Revenue 3.4 Global Biosimilar of Remicade Market Concentration Ratio 3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2020 3.5 Biosimilar of Remicade Key Players Head office and Area Served 3.6 Key Players Biosimilar of Remicade Product Solution and Service 3.7 Date of Enter into Biosimilar of Remicade Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biosimilar of Remicade Breakdown Data by Type 4.1 Global Biosimilar of Remicade Historic Market Size by Type (2016-2021) 4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2022-2027) 5 Biosimilar of Remicade Breakdown Data by Application 5.1 Global Biosimilar of Remicade Historic Market Size by Application (2016-2021) 5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Biosimilar of Remicade Market Size (2016-2027) 6.2 North America Biosimilar of Remicade Market Size by Type 6.2.1 North America Biosimilar of Remicade Market Size by Type (2016-2021) 6.2.2 North America Biosimilar of Remicade Market Size by Type (2022-2027) 6.2.3 North America Biosimilar of Remicade Market Size by Type (2016-2027) 6.3 North America Biosimilar of Remicade Market Size by Application 6.3.1 North America Biosimilar of Remicade Market Size by Application (2016-2021) 6.3.2 North America Biosimilar of Remicade Market Size by Application (2022-2027) 6.3.3 North America Biosimilar of Remicade Market Size by Application (2016-2027) 6.4 North America Biosimilar of Remicade Market Size by Country 6.4.1 North America Biosimilar of Remicade Market Size by Country (2016-2021) 6.4.2 North America Biosimilar of Remicade Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Biosimilar of Remicade Market Size (2016-2027) 7.2 Europe Biosimilar of Remicade Market Size by Type 7.2.1 Europe Biosimilar of Remicade Market Size by Type (2016-2021) 7.2.2 Europe Biosimilar of Remicade Market Size by Type (2022-2027) 7.2.3 Europe Biosimilar of Remicade Market Size by Type (2016-2027) 7.3 Europe Biosimilar of Remicade Market Size by Application 7.3.1 Europe Biosimilar of Remicade Market Size by Application (2016-2021) 7.3.2 Europe Biosimilar of Remicade Market Size by Application (2022-2027) 7.3.3 Europe Biosimilar of Remicade Market Size by Application (2016-2027) 7.4 Europe Biosimilar of Remicade Market Size by Country 7.4.1 Europe Biosimilar of Remicade Market Size by Country (2016-2021) 7.4.2 Europe Biosimilar of Remicade Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Biosimilar of Remicade Market Size (2016-2027) 8.2 Asia-Pacific Biosimilar of Remicade Market Size by Type 8.2.1 Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Biosimilar of Remicade Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2027) 8.3 Asia-Pacific Biosimilar of Remicade Market Size by Application 8.3.1 Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Biosimilar of Remicade Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2027) 8.4 Asia-Pacific Biosimilar of Remicade Market Size by Region 8.4.1 Asia-Pacific Biosimilar of Remicade Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Biosimilar of Remicade Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biosimilar of Remicade Market Size (2016-2027) 9.2 Latin America Biosimilar of Remicade Market Size by Type 9.2.1 Latin America Biosimilar of Remicade Market Size by Type (2016-2021) 9.2.2 Latin America Biosimilar of Remicade Market Size by Type (2022-2027) 9.2.3 Latin America Biosimilar of Remicade Market Size by Type (2016-2027) 9.3 Latin America Biosimilar of Remicade Market Size by Application 9.3.1 Latin America Biosimilar of Remicade Market Size by Application (2016-2021) 9.3.2 Latin America Biosimilar of Remicade Market Size by Application (2022-2027) 9.3.3 Latin America Biosimilar of Remicade Market Size by Application (2016-2027) 9.4 Latin America Biosimilar of Remicade Market Size by Country 9.4.1 Latin America Biosimilar of Remicade Market Size by Country (2016-2021) 9.4.2 Latin America Biosimilar of Remicade Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biosimilar of Remicade Market Size (2016-2027) 10.2 Middle East & Africa Biosimilar of Remicade Market Size by Type 10.2.1 Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Biosimilar of Remicade Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2027) 10.3 Middle East & Africa Biosimilar of Remicade Market Size by Application 10.3.1 Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Biosimilar of Remicade Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2027) 10.4 Middle East & Africa Biosimilar of Remicade Market Size by Country 10.4.1 Middle East & Africa Biosimilar of Remicade Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Biosimilar of Remicade Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Biosimilar of Remicade Introduction 11.1.4 Roche Revenue in Biosimilar of Remicade Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Biosimilar of Remicade Introduction 11.2.4 Amgen Revenue in Biosimilar of Remicade Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 AbbVie 11.3.1 AbbVie Company Details 11.3.2 AbbVie Business Overview 11.3.3 AbbVie Biosimilar of Remicade Introduction 11.3.4 AbbVie Revenue in Biosimilar of Remicade Business (2016-2021) 11.3.5 AbbVie Recent Development 11.4 Sanofi-Aventis 11.4.1 Sanofi-Aventis Company Details 11.4.2 Sanofi-Aventis Business Overview 11.4.3 Sanofi-Aventis Biosimilar of Remicade Introduction 11.4.4 Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2016-2021) 11.4.5 Sanofi-Aventis Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Biosimilar of Remicade Introduction 11.5.4 Johnson & Johnson Revenue in Biosimilar of Remicade Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Biosimilar of Remicade Introduction 11.6.4 Pfizer Revenue in Biosimilar of Remicade Business (2016-2021) 11.6.5 Pfizer Recent Development 11.7 Novo Nordisk 11.7.1 Novo Nordisk Company Details 11.7.2 Novo Nordisk Business Overview 11.7.3 Novo Nordisk Biosimilar of Remicade Introduction 11.7.4 Novo Nordisk Revenue in Biosimilar of Remicade Business (2016-2021) 11.7.5 Novo Nordisk Recent Development 11.8 Eli Lilly 11.8.1 Eli Lilly Company Details 11.8.2 Eli Lilly Business Overview 11.8.3 Eli Lilly Biosimilar of Remicade Introduction 11.8.4 Eli Lilly Revenue in Biosimilar of Remicade Business (2016-2021) 11.8.5 Eli Lilly Recent Development 11.9 Novartis 11.9.1 Novartis Company Details 11.9.2 Novartis Business Overview 11.9.3 Novartis Biosimilar of Remicade Introduction 11.9.4 Novartis Revenue in Biosimilar of Remicade Business (2016-2021) 11.9.5 Novartis Recent Development 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview 11.10.3 Merck Biosimilar of Remicade Introduction 11.10.4 Merck Revenue in Biosimilar of Remicade Business (2016-2021) 11.10.5 Merck Recent Development 11.11 3sbio 11.11.1 3sbio Company Details 11.11.2 3sbio Business Overview 11.11.3 3sbio Biosimilar of Remicade Introduction 11.11.4 3sbio Revenue in Biosimilar of Remicade Business (2016-2021) 11.11.5 3sbio Recent Development 11.12 Changchun High Tech 11.12.1 Changchun High Tech Company Details 11.12.2 Changchun High Tech Business Overview 11.12.3 Changchun High Tech Biosimilar of Remicade Introduction 11.12.4 Changchun High Tech Revenue in Biosimilar of Remicade Business (2016-2021) 11.12.5 Changchun High Tech Recent Development 11.13 CP Guojian 11.13.1 CP Guojian Company Details 11.13.2 CP Guojian Business Overview 11.13.3 CP Guojian Biosimilar of Remicade Introduction 11.13.4 CP Guojian Revenue in Biosimilar of Remicade Business (2016-2021) 11.13.5 CP Guojian Recent Development 11.14 Biotech 11.14.1 Biotech Company Details 11.14.2 Biotech Business Overview 11.14.3 Biotech Biosimilar of Remicade Introduction 11.14.4 Biotech Revenue in Biosimilar of Remicade Business (2016-2021) 11.14.5 Biotech Recent Development 11.15 Gelgen 11.15.1 Gelgen Company Details 11.15.2 Gelgen Business Overview 11.15.3 Gelgen Biosimilar of Remicade Introduction 11.15.4 Gelgen Revenue in Biosimilar of Remicade Business (2016-2021) 11.15.5 Gelgen Recent Development 11.16 Innovent 11.16.1 Innovent Company Details 11.16.2 Innovent Business Overview 11.16.3 Innovent Biosimilar of Remicade Introduction 11.16.4 Innovent Revenue in Biosimilar of Remicade Business (2016-2021) 11.16.5 Innovent Recent Development 11.17 Dong Bao 11.17.1 Dong Bao Company Details 11.17.2 Dong Bao Business Overview 11.17.3 Dong Bao Biosimilar of Remicade Introduction 11.17.4 Dong Bao Revenue in Biosimilar of Remicade Business (2016-2021) 11.17.5 Dong Bao Recent Development 11.18 Ganlee 11.18.1 Ganlee Company Details 11.18.2 Ganlee Business Overview 11.18.3 Ganlee Biosimilar of Remicade Introduction 11.18.4 Ganlee Revenue in Biosimilar of Remicade Business (2016-2021) 11.18.5 Ganlee Recent Development 11.18 United Laboratories .1 United Laboratories Company Details .2 United Laboratories Business Overview .3 United Laboratories Biosimilar of Remicade Introduction .4 United Laboratories Revenue in Biosimilar of Remicade Business (2016-2021) .5 United Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Biosimilar of Remicade Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Interferon Table 4. Key Players of Erythropoietin Table 5. Key Players of Insulin Table 6. Key Players of Vaccines Table 7. Key Players of Other Table 8. Global Biosimilar of Remicade Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Biosimilar of Remicade Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Biosimilar of Remicade Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Biosimilar of Remicade Market Share by Regions (2016-2021) Table 12. Global Biosimilar of Remicade Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Biosimilar of Remicade Market Share by Regions (2022-2027) Table 14. Biosimilar of Remicade Market Trends Table 15. Biosimilar of Remicade Market Drivers Table 16. Biosimilar of Remicade Market Challenges Table 17. Biosimilar of Remicade Market Restraints Table 18. Global Biosimilar of Remicade Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Biosimilar of Remicade Market Share by Players (2016-2021) Table 20. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar of Remicade as of 2020) Table 21. Ranking of Global Top Biosimilar of Remicade Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Biosimilar of Remicade Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Biosimilar of Remicade Product Solution and Service Table 25. Date of Enter into Biosimilar of Remicade Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million) Table 28. Global Biosimilar of Remicade Revenue Market Share by Type (2016-2021) Table 29. Global Biosimilar of Remicade Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Biosimilar of Remicade Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Biosimilar of Remicade Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Biosimilar of Remicade Revenue Market Share by Application (2016-2021) Table 33. Global Biosimilar of Remicade Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Biosimilar of Remicade Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million) Table 36. North America Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million) Table 38. North America Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Biosimilar of Remicade Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Biosimilar of Remicade Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million) Table 65. Roche Company Details Table 66. Roche Business Overview Table 67. Roche Biosimilar of Remicade Product Table 68. Roche Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 69. Roche Recent Development Table 70. Amgen Company Details Table 71. Amgen Business Overview Table 72. Amgen Biosimilar of Remicade Product Table 73. Amgen Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 74. Amgen Recent Development Table 75. AbbVie Company Details Table 76. AbbVie Business Overview Table 77. AbbVie Biosimilar of Remicade Product Table 78. AbbVie Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 79. AbbVie Recent Development Table 80. Sanofi-Aventis Company Details Table 81. Sanofi-Aventis Business Overview Table 82. Sanofi-Aventis Biosimilar of Remicade Product Table 83. Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 84. Sanofi-Aventis Recent Development Table 85. Johnson & Johnson Company Details Table 86. Johnson & Johnson Business Overview Table 87. Johnson & Johnson Biosimilar of Remicade Product Table 88. Johnson & Johnson Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 89. Johnson & Johnson Recent Development Table 90. Pfizer Company Details Table 91. Pfizer Business Overview Table 92. Pfizer Biosimilar of Remicade Product Table 93. Pfizer Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 94. Pfizer Recent Development Table 95. Novo Nordisk Company Details Table 96. Novo Nordisk Business Overview Table 97. Novo Nordisk Biosimilar of Remicade Product Table 98. Novo Nordisk Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 99. Novo Nordisk Recent Development Table 100. Eli Lilly Company Details Table 101. Eli Lilly Business Overview Table 102. Eli Lilly Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 103. Eli Lilly Recent Development Table 104. Novartis Company Details Table 105. Novartis Business Overview Table 106. Novartis Biosimilar of Remicade Product Table 107. Novartis Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 108. Novartis Recent Development Table 109. Merck Company Details Table 110. Merck Business Overview Table 111. Merck Biosimilar of Remicade Product Table 112. Merck Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 113. Merck Recent Development Table 114. 3sbio Company Details Table 115. 3sbio Business Overview Table 116. 3sbio Biosimilar of Remicade Product Table 117. 3sbio Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 118. 3sbio Recent Development Table 119. Changchun High Tech Company Details Table 120. Changchun High Tech Business Overview Table 121. Changchun High Tech Biosimilar of Remicade Product Table 122. Changchun High Tech Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 123. Changchun High Tech Recent Development Table 124. CP Guojian Company Details Table 125. CP Guojian Business Overview Table 126. CP Guojian Biosimilar of Remicade Product Table 127. CP Guojian Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 128. CP Guojian Recent Development Table 129. Biotech Company Details Table 130. Biotech Business Overview Table 131. Biotech Biosimilar of Remicade Product Table 132. Biotech Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 133. Biotech Recent Development Table 134. Gelgen Company Details Table 135. Gelgen Business Overview Table 136. Gelgen Biosimilar of Remicade Product Table 137. Gelgen Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 138. Gelgen Recent Development Table 139. Innovent Company Details Table 140. Innovent Business Overview Table 141. Innovent Biosimilar of Remicade Product Table 142. Innovent Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 143. Innovent Recent Development Table 144. Dong Bao Company Details Table 145. Dong Bao Business Overview Table 146. Dong Bao Biosimilar of Remicade Product Table 147. Dong Bao Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 148. Dong Bao Recent Development Table 149. Ganlee Company Details Table 150. Ganlee Business Overview Table 151. Ganlee Biosimilar of Remicade Product Table 152. Ganlee Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 153. Ganlee Recent Development Table 154. United Laboratories Company Details Table 155. United Laboratories Business Overview Table 156. United Laboratories Biosimilar of Remicade Product Table 157. United Laboratories Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million) Table 158. United Laboratories Recent Development Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. Global Biosimilar of Remicade Market Share by Type: 2020 VS 2027 Figure 2. Monoclonal Antibodies Features Figure 3. Interferon Features Figure 4. Erythropoietin Features Figure 5. Insulin Features Figure 6. Vaccines Features Figure 7. Other Features Figure 8. Global Biosimilar of Remicade Market Share by Application: 2020 VS 2027 Figure 9. Tumor Case Studies Figure 10. Diabetes Case Studies Figure 11. Cardiovascular Case Studies Figure 12. Hemophilia Case Studies Figure 13. Other Case Studies Figure 14. Biosimilar of Remicade Report Years Considered Figure 15. Global Biosimilar of Remicade Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Biosimilar of Remicade Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Biosimilar of Remicade Market Share by Regions: 2020 VS 2027 Figure 18. Global Biosimilar of Remicade Market Share by Regions (2022-2027) Figure 19. Global Biosimilar of Remicade Market Share by Players in 2020 Figure 20. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar of Remicade as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2020 Figure 22. Global Biosimilar of Remicade Revenue Market Share by Type (2016-2021) Figure 23. Global Biosimilar of Remicade Revenue Market Share by Type (2022-2027) Figure 24. North America Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Biosimilar of Remicade Market Share by Type (2016-2027) Figure 26. North America Biosimilar of Remicade Market Share by Application (2016-2027) Figure 27. North America Biosimilar of Remicade Market Share by Country (2016-2027) Figure 28. United States Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Biosimilar of Remicade Market Share by Type (2016-2027) Figure 32. Europe Biosimilar of Remicade Market Share by Application (2016-2027) Figure 33. Europe Biosimilar of Remicade Market Share by Country (2016-2027) Figure 34. Germany Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Biosimilar of Remicade Market Share by Type (2016-2027) Figure 42. Asia-Pacific Biosimilar of Remicade Market Share by Application (2016-2027) Figure 43. Asia-Pacific Biosimilar of Remicade Market Share by Region (2016-2027) Figure 44. China Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Biosimilar of Remicade Market Share by Type (2016-2027) Figure 52. Latin America Biosimilar of Remicade Market Share by Application (2016-2027) Figure 53. Latin America Biosimilar of Remicade Market Share by Country (2016-2027) Figure 54. Mexico Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Biosimilar of Remicade Market Share by Type (2016-2027) Figure 58. Middle East & Africa Biosimilar of Remicade Market Share by Application (2016-2027) Figure 59. Middle East & Africa Biosimilar of Remicade Market Share by Country (2016-2027) Figure 60. Turkey Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Roche Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 64. Amgen Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 65. AbbVie Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 66. Sanofi-Aventis Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 67. Johnson & Johnson Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 68. Pfizer Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 69. Novo Nordisk Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 70. Eli Lilly Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 71. Novartis Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 72. Merck Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 73. 3sbio Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 74. Changchun High Tech Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 75. CP Guojian Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 76. Biotech Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 77. Gelgen Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 78. Innovent Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 79. Dong Bao Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 80. Ganlee Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 81. United Laboratories Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021) Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed

Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck 3sbio Changchun High Tech CP Guojian Biotech Gelgen Innovent Dong Bao Ganlee United Laboratories